Stocksigma LogoStocksigma Logo

Bafna Pharmaceuticals Reports Q2 FY27 Results with Net Profit Reaching INR 684.82 Lakhs

Bafna Pharmaceuticals reported revenue from operations of INR 4,766.56 Lakhs for the quarter ended 30th Sep'26, up 34.39% YoY compared to INR 3,546.82

Bafna Pharmaceuticals Reports Q2 FY27 Results with Net Profit Reaching INR 684.82 Lakhs

Bafna Pharmaceuticals Ltd 路 Outcome 路 11 Nov 2026, 10:23 pm

Bafna Pharmaceuticals Reports Q2 FY27 Results with Net Profit Reaching INR 684.82 Lakhs Bafna Pharmaceuticals reported revenue from operations of INR 4,766.56 Lakhs for the quarter ended 30th Sep'26, up 34.39% YoY compared to INR 3,546.82 Lakhs in the prior-year period. Net profit surged 119.15% YoY to INR 684.82 Lakhs versus INR 312.49 Lakhs in Q2 FY26, with quarterly EPS rising to INR 2.89. For the half-year ended 30th Sep'26, revenue stood at INR 7,424.88 Lakhs and net profit reached INR 692.33 Lakhs. Auditors highlighted an emphasis of matter regarding disputed GST demands and recovery orders totaling INR 566.56 Lakhs.

Original exchange filing (PDF)

More announcements from Bafna Pharmaceuticals Ltd

All Bafna Pharmaceuticals Ltd announcements